Multiple Myeloma

A groundbreaking presentation on AQUILA, COBRA, TecLLE, and MajesTEC-3 trials highlighting innovative signal shifts in myeloma management by leading oncology experts.

Multiple Myeloma

02/24/2026

AQUILA, COBRA, TecLILLE, and MajesTEC-3 Trials Signal Shifts in Myeloma Management

Ben Derman, MDRahul Gosain, MD, MBARohit Gosain, MD

Multiple Myeloma

01/16/2026

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

Hamza Hashmi, MDShreyas Kalantri, MD

Prognostic criteria and role of Daratumumab in high-risk smoldering myeloma, featuring experts Jing Wang, MD and Anuja Abhyankar, MD, discussing recent advancements in multiple myeloma treatment.

Multiple Myeloma

01/08/2026

Early Intervention Strategies in High-Risk Smoldering Multiple Myeloma

Anuja V. Abhyankar, MDJing Wang, MD

$1. Researchers and clinicians discuss strategies for managing lenalidomide, CD38, and multi-refractory disease in relapsed multiple myeloma treatment at OncUpdates conference.$

Multiple Myeloma

01/04/2026

How to Select Treatment in Relapsed Multiple Myeloma

Anuja V. Abhyankar, MDS. Vincent Rajkumar, MD

Multiple Myeloma

01/03/2026

Bispecific Antibodies and CAR T Redefine Early-Line Treatment in Multiple Myeloma

Robert Orlowski, MD, PhDHamza Hashmi, MD

Pre-transplant functional status as a predictor of autologous myeloma transplant outcomes, featuring Rahul Gosain, MD, MBA and Sawyer Bawek, DO, with a cityscape background.

Multiple Myeloma

12/29/2025

Pretransplant Functional Status as a Predictor of Outcomes in Multiple Myeloma

Sawyer Bawek, DORahul Gosain, MD, MBA